Other Viruses Citation List:
January 20 - February 2, 2012
Hepatitis B virus
1. Synthesis, Characterization and Biological Activity of a Niobium-substituted-heteropolytungstate on Hepatitis B Virus. Zhang, H., Y. Qi, Y. Ding, J. Wang, Q. Li, J. Zhang, Y. Jiang, X. Chi, J. Li, and J. Niu, Bioorganic & Medicinal Chemistry Letters, 2012. [Epub ahead of print]; PMID[22264474].
[PubMed]. OV_0120-020212.
Hepatitis C virus
2. Synthesis and Antiviral Evaluation of 7-O-Arylmethylquercetin Derivatives against SARS-associated Coronavirus (SCV) and Hepatitis C Virus (HCV). Park, H.R., H. Yoon, M.K. Kim, S.D. Lee, and Y. Chong, Archives of Pharmacal Research, 2012. 35(1): p. 77-85; PMID[22297745].
[PubMed]. OV_0120-020212.
3. Fluoroquinolones Inhibit HCV by Targeting Its Helicase. Khan, I.A., S. Siddiqui, S. Rehmani, S.U. Kazmi, and S.H. Ali, Antiviral Therapy, 2011. [Epub ahead of print]; PMID[22293206].
[PubMed]. OV_0120-020212.
4. Inhibition of Hepatitis C Virus NS5B Polymerase by S-Trityl-l-cysteine Derivatives. Nichols, D.B., G. Fournet, K.R. Gurukumar, A. Basu, J.C. Lee, N. Sakamoto, F. Kozielski, I. Musmuca, B. Joseph, R. Ragno, and N. Kaushik-Basu, European Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22280819].
[PubMed]. OV_0120-020212.
5. Evaluation of ITX 5061, a Scavenger Receptor B1 Antagonist: Resistance Selection and Activity in Combination With Other Hepatitis C Virus Antivirals. Zhu, H., F. Wong-Staal, H. Lee, A. Syder, J. McKelvy, R.T. Schooley, and D.L. Wyles, The Journal of Infectious Diseases, 2012. 205(4): p. 656-662; PMID[22279172].
[PubMed]. OV_0120-020212.
6. Insight into the Structural Requirements of Narlaprevir-type Inhibitors of NS3/NS4A Protease Based on HQSAR and Molecular Field Analyses. Zhu, J., Y. Li, H. Yu, L. Zhang, X. Mao, and T. Hou, Combinatorial Chemistry & High Throughput Screening, 2012. [Epub ahead of print]; PMID[22263860].
[PubMed]. OV_0120-020212.
Citations from the ISI Web of Knowledge Listings for O.V.
7. In Vitro Selection and Characterization of HCV Replicons Resistant to Multiple Non-nucleoside Polymerase Inhibitors. Delang, L., I. Vliegen, P. Leyssen, and J. Neyts, Journal of Hepatology, 2012. 56(1): p. 41-48; ISI[000298484500012].
[WOS]. OV_0120-020212.
8. 1,3,4-Oxadiazole: A Privileged Structure in Antiviral Agents. Li, Z., P. Zhan, and X. Liu, Mini-Reviews in Medicinal Chemistry, 2011. 11(13): p. 1130-1142; ISI[000298498000004].
[WOS]. OV_0120-020212.
9. Inhibition on Hepatitis B Virus E-gene Expression of 10-23 DNAzyme Delivered by Novel Chitosan Oligosaccharide-stearic acid Micelles. Miao, J., X.G. Zhang, Y. Hong, Y.F. Rao, Q. Li, X.J. Xie, J.E. Wo, and M.W. Li, Carbohydrate Polymers, 2012. 87(2): p. 1342-1347; ISI[000298305400051]. [WOS]. OV_0120-020212.